Select Medical Completes $1.7B Take-Private Merger, Delists from NYSE
Summary
Select Medical Holdings Corp. has completed its take-private merger, delisting from the NYSE and converting all public shares to cash at $16.50 per share.
Key Events · M&A and Partnerships · SEM
-
Merger Consummated
Select Medical Holdings Corp. completed its take-private acquisition by a consortium led by its Executive Chairman, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe.
-
Share Conversion
All outstanding common shares were converted into the right to receive $16.50 per share in cash, valuing the company at approximately $1.7 billion.
-
NYSE Delisting
The company's common stock ceased trading and was delisted from the New York Stock Exchange as of July 1, 2026, with plans to deregister its shares and suspend reporting obligations.
-
Financing Secured
The merger was partially financed by a new $1 billion incremental term loan under an amended credit agreement.
Analysis · SEM · Industrial Applications And Services
Select Medical Holdings Corp. has finalized its take-private acquisition by a consortium, converting all outstanding shares into cash at $16.50 per share. This transaction, valued at approximately $1.7 billion, marks the end of the company's public trading on the NYSE and its transition to a wholly-owned subsidiary. The deal was financed in part by a new $1 billion incremental term loan.
At the time of this filing, SEM was trading at $16.52 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. This filing was assessed with neutral market sentiment and an importance score of 10 out of 10.